Showing results (2221-2230 of 8,982) with videos related to
Sort By:
Pageof 899
Journal of Hepatology|December 3, 2022
Decreased propionyl-CoA metabolism facilitates metabolic reprogramming and promotes hepatocellular carcinomaJiaqi Sun, Jun Ding, Qingsong Shen, et al.Journal of Hepatology|July 7, 2022
COVID-19 positive donor for solid organ transplantationMaddalena Peghin, Paolo Antonio GrossiJournal of Hepatology|December 1, 2022
Using mouse liver cancer models based on somatic genome editing to predict immune checkpoint inhibitor responsesVincent Wai-Hin Yuen, David Kung-Chun Chiu, Cheuk-Ting Law, et al.Journal of Hepatology|June 10, 2022
Liver stiffness not fatty liver disease is associated with atrial fibrillation: The Rotterdam studyLaurens A van Kleef, Zuolin Lu, M Arfan Ikram, et al.Journal of Hepatology|June 24, 2022
TREM-2 plays a protective role in cholestasis by acting as a negative regulator of inflammationIbone Labiano, Aloña Agirre-Lizaso, Paula Olaizola, et al.Journal of Hepatology|June 24, 2022
Whole blood microRNAs capture systemic reprogramming and have diagnostic potential in patients with biliary tract cancerDan Høgdall, Colm J O'Rourke, Finn O Larsen, et al.Journal of Hepatology|June 26, 2022
NUDT1 promotes the accumulation and longevity of CD103+ TRM cells in primary biliary cholangitisBingyuan Huang, Zhuwan Lyu, Qiwei Qian, et al.Journal of Hepatology|November 25, 2022
Integrating genetic variants into clinical models for hepatocellular carcinoma risk stratification in cirrhosisPierre Nahon, Jessica Bamba-Funck, Richard Layese, et al.Journal of Hepatology|June 17, 2022
The Slc25a47 locus is a novel determinant of hepatic mitochondrial function implicated in liver fibrosisNadia Bresciani, Hadrien Demagny, Vera Lemos, et al.Journal of Hepatology|June 17, 2022
Phase IIa, randomised, double-blind study of GSK3389404 in patients with chronic hepatitis B on stable nucleos(t)ide therapyMan-Fung Yuen, Jeong Heo, Hiromitsu Kumada, et al.Pageof 899